LANCASTER, Calif.--(BUSINESS WIRE)--Sept. 20, 2006--Simulations Plus, Inc. (AMEX:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that it has released version 2.0 of its best-in-class ADMET Predictor(TM) software product. ADMET Predictor is a software program that takes molecular structures as input, and generates predictions for approximately 50 different critical ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties. Because these predictions can be made in the earliest stages of drug discovery, the considered molecules need exist only as chemical structure drawings in a computer. Thus, scientists can identify drug candidates that are likely to fail before they are synthesized, avoiding the time and cost of making and testing them, and allowing scarce resources to be focused on those compounds that are more likely to succeed.
